NEU 6.46% $15.63 neuren pharmaceuticals limited

Average for any drug is 5 years to peak sales. Daybue sales have...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,522 Posts.
    lightbulb Created with Sketch. 906
    Average for any drug is 5 years to peak sales. Daybue sales have actually been remarkable given the GI issues they have contended with, issues that they are clearly starting to get on top of. Still on track to be a blockbuster drug. Clearly there are 'some issues' but they are far from dire, sales continue to grow with some positives indicating growth and retention will likely both trend stronger in the future, and this is still a life changing drug for many families with Rett's and will be for many more that have not yet started.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.63
Change
-1.080(6.46%)
Mkt cap ! $1.997B
Open High Low Value Volume
$16.61 $16.65 $15.54 $8.354M 529.4K

Buyers (Bids)

No. Vol. Price($)
3 830 $15.60
 

Sellers (Offers)

Price($) Vol. No.
$15.74 1484 2
View Market Depth
Last trade - 16.10pm 18/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.